$590m cobalt, copper and gold in the ground., page-5

First 5 Last

Share
Profile

Follow
billyen

6,892 Posts.

2861

03/10/16

05:47

Post #: 19572209
Share

Originally posted by zinvestor ↑

The market has completely overlooked the Wee Macgregor Co, Cu, Au project. This project can add $50m to the market cap quick when it's picked up by the market in my view.

The lithium assets are game changing and will re rate AGY big time with expected results.. However after being reminded about Wee macgregor on their Twitter page I just done the numbers on The project and massive upside potential is an understatement.

All in Australian dollars AGY have about $40m worth of cobalt in the ground from Jorc and another $40m worth in the exploration target.

Cobalt forecasted to double from here. Upside is doubling of these numbers

About $170m in copper in JORC resource and $170m in exploration target.

Copper forecasted to be in deficit next year, this revenue can double or triple in the next couple years.

And about another $170m in gold credits also.

Basically wee macgregor has $590m of product in the ground with what they now is there and at current prices, the whole project hasn't been drilled out and all commodities forecasted to do well over the 12 to 24 months.

This can be in production relatively quickly also as CFE has done a lot of work to have it mine ready.

hidden gem.
DYOR

Expand

Well done.
I knew of this but, never did the numbers.

It's good to know that even if every Li project failed. AGY is still a mutli -bagger.

AGY also has mining assets which are the correct ones for EV and battery storage. Both of these are the future and AGY is one of the few with project in both!

AGY Price at posting: 2.3¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 56 more messages in this thread...

First 5 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.001(2.63%)		Mkt cap ! $58.96M

Open	High	Low	Value	Volume
4.0¢	4.1¢	3.9¢	$303.9K	7.541M

Buyers (Bids)

No.	Vol.	Price($)
3	304999	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
3	304999	0.039
7	563206	0.038
6	848648	0.037
23	2310708	0.036
25	2513178	0.035

Price($)	Vol.	No.
0.040	25000	1
0.041	406425	2
0.042	751292	7
0.043	1956941	3
0.044	1035285	9

Last trade - 16.10pm 07/10/2024 (20 minute delay)

AGY (ASX) Chart

$590m cobalt, copper and gold in the ground., page-5

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

$590m cobalt, copper and gold in the ground., page-5

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News